Jill Feldman, Lung cancer Patient and Advocate, Co-Founder of EGFR Resisters, shared a post on X:
“Deadline is approaching!
Are you doing research in EGFR+ lung cancer – OR mentoring someone who is?
Submit an abstract the EGFR Resisters Research Summit for a chance to join us in Chicago to present your work, network with KOLs, colleagues, and patient advocates.
Concepts are always welcome!
Deadline – August 8.
More posts featuring Jill Feldman on OncoDaily.